LCK and neoplasm: CAR T cells overexpressing LCK effectively controlled tumor progression at an early stage, but the effect was not as long-lasting as that of ZAP70 or C-JUN, whereas overexpression of C-JUN showed the greatest effect in improving tumor control and prolonging mouse survival (Fig. 4C–E).